CareCloud's Proxy Proposal: Fueling Future Growth
CareCloud, Inc. (Nasdaq: CCLD, CCLDO, CCLDP) has recently made headlines with its decision to solicit proxies from shareholders, aiming to approve a significant increase in the number of authorized shares. This strategic move is crucial for supporting the company's ongoing growth initiatives and operational objectives.
Driving Vision of Growth
The call for increased authorized shares resonates strongly with Mahmud Haq, the Founder and Executive Chairman of CareCloud. With a firm grip on the company's future, Haq highlighted the board's initiative as necessary for propelling revenue and profitability. As major stakeholders, the board and executive team own over 38% of the Common Stock, underscoring their vested interest in ensuring the company's growth trajectory continues upward.
Over the past decade, CareCloud has exhibited impressive performance, sustaining a compound annual growth rate (CAGR) of 23%. This success stems from a combination of strategic acquisitions and organic growth initiatives, positioning CareCloud as a leader in healthcare information technology and AI solutions. Importantly, the company achieved over $10 million in free cash flow during the first three quarters of the fiscal year and marked a notable 50% increase in adjusted EBITDA year-over-year.
Understanding the Proposal
The core of CareCloud's proposal aims to elevate the number of authorized shares of Common Stock from 35 million to an ambitious 85 million. This increase is vital for providing the flexibility needed to explore strategic growth avenues, incorporating future acquisitions, and facilitating the potential conversion of outstanding Preferred Stock to Common Stock. Moreover, it equips the company to invest more effectively in organic growth and prioritize various corporate objectives.
To further engage shareholders, CareCloud has scheduled a Special Meeting for Common Stock Shareholders on January 27, 2025. Shareholders who hold stocks as of December 3, 2024, are eligible to vote on this significant proposal. Detailed information regarding the Proxy can be found on the company’s official website.
How to Participate in the Voting Process
Participation in the upcoming vote is paramount as it allows shareholders to voicing their opinions on this crucial initiative. CareCloud emphasizes that shareholders can vote through various convenient methods:
E-Voting
Shareholders can cast their votes online by visiting the designated website of the company's transfer agent. They will need their control number and must complete voting before the deadline of January 23, 2025, at 11:59 PM Eastern Time.
Voting by Mail
For those who prefer traditional methods, shareholders can mark, sign, and return their proxy cards in the provided postage-paid envelope. It’s critical that these proxies arrive by the voting deadline for them to be counted.
Attend the Special Meeting
Shareholders are also encouraged to attend the Special Meeting in person on January 27, 2025, where they can vote and engage directly with the company’s leadership.
About CareCloud
CareCloud is committed to innovating healthcare delivery through its comprehensive array of technology-enabled solutions. The company's offerings include revenue cycle management (RCM), practice management (PM), electronic health records (EHR), patient experience management (PXM), and digital health solutions, all designed to enhance operational performance and streamline clinical workflows. More than 40,000 providers trust CareCloud to support their care delivery while minimizing administrative overhead and costs.
Conclusion
In summary, CareCloud's initiative to increase its authorized shares reflects a broader ambition to foster growth and profitability in today's competitive healthcare landscape. As the company prepares for its Special Meeting of Shareholders, the engagement of its stakeholder base will be more critical than ever to ensure its strategic vision is aligned with shareholder interests.
Frequently Asked Questions
What is the proposed increase in authorized shares by CareCloud?
CareCloud seeks to increase its authorized shares from 35 million to 85 million to bolster its strategic growth initiatives.
Why is CareCloud planning to increase authorized shares?
The increase is intended to provide flexibility for future acquisitions and allow potential conversion of Preferred Stock to Common Stock while enhancing organic growth investments.
When is the Special Meeting for shareholders?
The Special Meeting is scheduled for January 27, 2025, allowing eligible shareholders to cast their votes on the proposal.
How can shareholders participate in the voting process?
Shareholders can vote through e-voting, by mail using proxy cards, or by attending the Special Meeting in person.
What primarily drives CareCloud's growth?
CareCloud's growth is driven by a synergy of acquisitions and organic product development, achieving a 23% CAGR over the last decade while maintaining a focus on profitability.
